Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2011 Jan 20;32(7):838–846. doi: 10.1093/eurheartj/ehq494

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2011. For permissions please email: journals.permissions@oup.com

The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oup.com.

PMC Copyright notice

Poor responders. Poor responder analyses were conducted at (A) 4 h post-loading dose; (B) 24 h post-loading dose; and (C) 7 days by VerifyNow^® (PRU >235), light transmission aggregometry (MPA >50% and IPA ≤20%), or vasodilator-stimulated phosphoprotein phosphorylation (PRI >50%) platelet function assays. P-values for comparison between treatment groups for each assay are indicated. MPA, maximum platelet aggregation to 20 µM ADP by light transmission aggregometry; IPA, inhibition of platelet aggregation with 20 µM ADP by light transmission aggregometry.